Literature DB >> 11561738

Lunelle monthly injectable contraceptive. An effective, safe, and convenient new birth control option.

A M Kaunitz1.   

Abstract

Lunelle, an injectable estrogen/progestin contraceptive, is administered on a monthly basis and is now available as the first monthly injectable in the United States. International and US clinical trials have established its safety and confirmed its contraceptive efficacy. Fertility returns rapidly after discontinuation of injections. Studies have noted a high level of patient satisfaction with Lunelle, suggesting that monthly injectable contraception will become a first-line contraceptive option in the United States.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561738     DOI: 10.1007/s004040100174

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  4 in total

1.  Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing.

Authors:  Annoesjka Novák; Christine de la Loge; Linda Abetz
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 2.  Combination injectable contraceptives for contraception.

Authors:  Maria F Gallo; David A Grimes; Laureen M Lopez; Kenneth F Schulz; Catherine d'Arcangues
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 3.  Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.

Authors:  Alexis J Bick; Renate Louw-du Toit; Salndave B Skosana; Donita Africander; Janet P Hapgood
Journal:  Pharmacol Ther       Date:  2020-12-13       Impact factor: 13.400

4.  Comparing the satisfaction and efficacy of Cyclofem and contraceptive pills among females in Northern Iran: A randomized controlled trial study.

Authors:  Bita Jamali; Azade Kiapoor; Mozhgan Firoozbakht; Fatemeh Kazeminavaei; Fatemeh Taghlili
Journal:  J Adv Pharm Technol Res       Date:  2014-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.